Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) Director Elizabeth Yeu Lin bought 9,506 shares of the stock in a transaction on Tuesday, August 15th. The shares were bought at an average price of $16.80 per share, for a total transaction of $159,700.80. Following the completion of the transaction, the director now directly owns 15,866 […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) Director Elizabeth Yeu Lin bought 9,506 shares of the firm’s stock in a transaction that occurred on Tuesday, August 15th. The shares were acquired at an average cost of $16.80 per share, for a total transaction of $159,700.80. Following the purchase, the director now directly owns 15,866 […]
Guggenheim restated their buy rating on shares of Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) in a report issued on Monday morning, Benzinga reports. They currently have a $46.00 price objective on the stock. TARS has been the topic of several other reports. William Blair assumed coverage on Tarsus Pharmaceuticals in a research report on Tuesday, […]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) was the recipient of a significant growth in short interest in the month of July. As of July 31st, there was short interest totalling 3,800,000 shares, a growth of 65.9% from the July 15th total of 2,290,000 shares. Based on an average daily volume of 383,100 shares, […]
Tarsus Pharmaceuticals (NASDAQ:TARS – Free Report) had its target price lowered by HC Wainwright from $50.00 to $42.00 in a research report report published on Friday morning, Marketbeat Ratings reports. HC Wainwright currently has a buy rating on the stock. TARS has been the topic of several other reports. Bank of America lifted their price […]